Continuous glucose monitoring during pregnancy for people with type 2 diabetes
Continuous glucose monitoring for management of type 2 diabetes in pregnancy (CGM2 trial)
This project tests whether wearing a continuous glucose monitor helps pregnant people with type 2 diabetes keep blood sugar in range and have healthier outcomes for themselves and their babies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11192784 on NIH RePORTER |
What this research studies
If you join, you would be asked to use a continuous glucose monitor during pregnancy and follow regular prenatal care with study visits to collect glucose and health information. The trial compares CGM use to usual fingerstick blood glucose monitoring and tracks both maternal and newborn outcomes such as glucose control, birth complications, and newborn health. Researchers will also look at what percent of glucose readings should be in the target range for people with type 2 diabetes in pregnancy. The study will pay attention to social and structural factors that affect diabetes care to try to help groups with worse outcomes.
Who could benefit from this research
Good fit: Pregnant people who have preexisting type 2 diabetes and are receiving prenatal care would be ideal candidates.
Not a fit: People with type 1 diabetes, those with only gestational diabetes, or individuals who cannot use wearable glucose devices are unlikely to benefit from this specific study.
Why it matters
Potential benefit: If successful, this could make daily blood sugar control easier in pregnancy and reduce complications for mothers and newborns.
How similar studies have performed: Similar trials in type 1 diabetes pregnancies showed better glucose control and fewer newborn complications, but CGM use specifically in type 2 diabetes pregnancies is not well studied.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Battarbee, Ashley Nicole — University of Alabama at Birmingham
- Study coordinator: Battarbee, Ashley Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.